Patent ductus arteriosus closure: Why same-dose oral ibuprofen is superior to intravenous

Thomas Bo Jensen; Jens Peter Kampmann; Jon Trærup Andersen

doi:10.1136/archdischild-2019-317755

Patent ductus arteriosus closure: Why same-dose oral ibuprofen is superior to intravenous

Thomas Bo Jensen^*, Jens Peter Kampmann, Jon Trærup Andersen

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Archives of Disease in Childhood: Fetal and Neonatal Edition
Vol/bind	105
Udgave nummer	3
Sider (fra-til)	340-340
Antal sider	1
ISSN	1359-2998
DOI	https://doi.org/10.1136/archdischild-2019-317755
Status	Udgivet - 2020

Adgang til dokumentet

10.1136/archdischild-2019-317755

Citationsformater

@article{930151c182f343d7ab611d0c5c7d5c15,

title = "Patent ductus arteriosus closure: Why same-dose oral ibuprofen is superior to intravenous",

keywords = "drug administration routes, ductus arteriosus, patent, ibuprofen, pharmacology, racemases and epimerases",

author = "Jensen, {Thomas Bo} and Kampmann, {Jens Peter} and {Tr{\ae}rup Andersen}, Jon",

year = "2020",

doi = "10.1136/archdischild-2019-317755",

language = "English",

volume = "105",

pages = "340--340",

journal = "Archives of Disease in Childhood",

issn = "0003-9888",

publisher = "B M J Group",

number = "3",

}

TY - JOUR

T1 - Patent ductus arteriosus closure

T2 - Why same-dose oral ibuprofen is superior to intravenous

AU - Jensen, Thomas Bo

AU - Kampmann, Jens Peter

AU - Trærup Andersen, Jon

PY - 2020

Y1 - 2020

KW - drug administration routes

KW - ductus arteriosus, patent

KW - ibuprofen

KW - pharmacology

KW - racemases and epimerases

U2 - 10.1136/archdischild-2019-317755

DO - 10.1136/archdischild-2019-317755

M3 - Letter

C2 - 31586941

AN - SCOPUS:85073411174

VL - 105

SP - 340

EP - 340

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 0003-9888

IS - 3

ER -